The estimated Net Worth of Anthony S Gibney is at least $5.49 millió dollars as of 17 April 2024. Mr Gibney owns over 100,000 units of IVERIC bio Inc stock worth over $3,995,000 and over the last 6 years he sold ISEE stock worth over $0. In addition, he makes $1,496,839 as Exec. VP and Chief Bus. & Strategy Officer at IVERIC bio Inc.
Sign up
Mr Gibney ISEE stock SEC Form 4 insiders trading
Mr has made over 3 trades of the IVERIC bio Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he bought 100,000 units of ISEE stock worth $130,000 on 17 April 2024.
The largest trade he's ever made was buying 100,000 units of IVERIC bio Inc stock on 17 April 2024 worth over $130,000. On average, Mr trades about 12,479 units every 55 days since 2018. As of 17 April 2024 he still owns at least 100,000 units of IVERIC bio Inc stock.
You can see the complete history of Mr Gibney stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Anthony S. Gibney biography
Anthony S. Gibney is the Exec. VP and Chief Bus. & Strategy Officer at IVERIC bio Inc.
What is the salary of Mr Gibney?
As the Exec. VP and Chief Bus. & Strategy Officer of IVERIC bio Inc, the total compensation of Mr Gibney at IVERIC bio Inc is $1,496,839. There are 2 executives at IVERIC bio Inc getting paid more, with Glenn Sblendorio having the highest compensation of $2,462,150.
How old is Mr Gibney?
Mr Gibney is 50, he's been the Exec. VP and Chief Bus. & Strategy Officer of IVERIC bio Inc since . There are 11 older and 3 younger executives at IVERIC bio Inc. The oldest executive at IVERIC bio Inc is Calvin Roberts, 67, who is the Independent Director.
What's Mr Gibney's mailing address?
Anthony's mailing address filed with the SEC is C/O CLEARSIDE BIOMEDICAL, INC., 900 NORTH POINT PARKWAY, SUITE 200, ALPHARETTA, GA, 30005.
Insiders trading at IVERIC bio Inc
Over the last 6 years, insiders at IVERIC bio Inc have traded over $8,677,595 worth of IVERIC bio Inc stock and bought 130,569 units worth $624,325 . The most active insiders traders include Glenn Sblendorio, Venture Capital Iv, L.P.Ver... és Keith Westby. On average, IVERIC bio Inc executives and independent directors trade stock every 15 days with the average trade being worth of $848,338. The most recent stock trade was executed by Keith Westby on 3 July 2023, trading 20,000 units of ISEE stock currently worth $58,800.
What does IVERIC bio Inc do?
we are a biopharmaceutical company specializing in the development of novel therapeutics to treat diseases of the back of the eye, with a focus on developing therapeutics for age-related macular degeneration (amd).
What does IVERIC bio Inc's logo look like?
Complete history of Mr Gibney stock trades at Clearside Biomedical Inc és IVERIC bio Inc
IVERIC bio Inc executives and stock owners
IVERIC bio Inc executives and other stock owners filed with the SEC include:
-
Glenn Sblendorio,
President, Chief Executive Officer, Director -
David Guyer,
Executive Chairman of the Board -
Anthony S. Gibney,
Exec. VP and Chief Bus. & Strategy Officer -
David Carroll,
Chief Financial Officer, Senior Vice President, Treasurer -
Keith Westby,
Chief Operating Officer, Senior Vice President -
Glenn P. Sblendorio M.B.A.,
CEO & Director -
Dr. Pravin U. Dugel M.D.,
Pres -
David F. Carroll M.B.A.,
Sr. VP, CFO & Treasurer -
Christopher Paul Simms,
Sr. VP & Chief Commercial Officer -
David F. Carroll,
Sr. VP, CFO & Treasurer -
Keith Westby M.B.A.,
Sr. VP & COO -
Calvin Roberts,
Independent Director -
Jane Henderson,
Independent Director -
Adrienne Graves,
Lead Independent Director -
Axel Bolte,
Independent Director -
Kathy Galante,
Vice President, Investor Relations and Corporate Communications -
Mark Blumenkranz,
Director -
Abraham Scaria,
Chief Scientific Officer -
Evelyn Harrison,
Sr. VP & Chief Clinical Operations Officer -
Amy R. Sheehan,
Sr. VP & Chief HR Officer -
Todd D.C. Anderman,
Sr. VP, Gen. Counsel & Corp. Sec. -
Dr. Xiao-Ping Dai Ph.D.,
Chief Technical Officer -
Dr. Samir C. Patel,
Co-Founder and Consultant -
Christopher Paul Simms,
SVP, Chief Commercial Officer -
Christine Ann Miller,
Director -
David E Redlick,
Director -
Venture Capital Iv, L.P.Ver...,
-
Anthony S Gibney,
EVP, Chief Business Officer -
Pravin Dugel,
President